Healthcare ❯ Drug Approval

FDA Regulations

Clinical Trials Weight Loss Medications Cancer Treatments Compounding Pharmacies Breakthrough Therapies Obesity Treatment Medication Shortages Rare Diseases Clinical Research

Lilly Sues Six U.S. Firms Over Black‑Market Sales of Experimental Drug Retatrutide

Lilly says the lawsuits are intended to force platforms and regulators to cut off an unsafe black‑market supply chain for its unapproved drug.

HSBC Cuts Eli Lilly to Reduce, Lowers Target to $850 on GLP-1 Reset

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch